Copper(II)/Rhodium(III)‐Catalyzed Three‐Component Sequential Annulation‐Olefination of 2‐Arylquinoxalines

Abstract The quinoxaline scaffold occurs in many pharmaceuticals, natural products and organic materials. In this study, a Cu(II)/Rh(III)‐catalyzed regioselective annulation‐olefination sequence for the formation and modification of quinoxalines was developed using ethanol and water as the solvent, with relatively broad substrate scope and functional group tolerance. This protocol has been successfully applied to the derivatization of natural products and pharmaceuticals. Additionally, the derivatives exhibited enhanced antiproliferative activities against A‐2780 and HCT‐116 cell lines, underscoring their potential as promising lead compounds for ovarian cancer and colon cancer treatment.

Authors

Institutions

Publication Details

Journal
European Journal of Organic Chemistry
Published
2024-08-31
DOI
https://doi.org/10.1002/ejoc.202400717
Primary Topic
Synthesis and Biological Evaluation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Copper(II)/Rhodium(III)‐Catalyzed Three‐Component Sequential Annulation‐Olefination of 2‐Arylquinoxalines

Fucheng Yin, Yifan Chen, Lingyi Kong, Yonglei Zhang et al.
European Journal of Organic Chemistry
Synthesis and Biological Evaluation
article

Copper(II)/Rhodium(III)‐Catalyzed Three‐Component Sequential Annulation‐Olefination of 2‐Arylquinoxalines

Fucheng Yin, Yifan Chen, Lingyi Kong, Yonglei Zhang, Xinxin Li, Xiaobing Wang, Shang Li, Siyuan Wan, Zhongwen Luo
article en

Abstract

Abstract The quinoxaline scaffold occurs in many pharmaceuticals, natural products and organic materials. In this study, a Cu(II)/Rh(III)‐catalyzed regioselective annulation‐olefination sequence for the formation and modification of quinoxalines was developed using ethanol and water as the solvent, with relatively broad substrate scope and functional group tolerance. This protocol has been successfully applied to the derivatization of natural products and pharmaceuticals. Additionally, the derivatives exhibited enhanced antiproliferative activities against A‐2780 and HCT‐116 cell lines, underscoring their potential as promising lead compounds for ovarian cancer and colon cancer treatment.

European Journal of Organic ChemistryVol. 27(44)
China Pharmaceutical University (CN)
National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, Government of Jiangsu Province, Six Talent Peaks Project in Jiangsu Province, Qinglan Project of Jiangsu Province of China, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health (111 Center)
Openalex Percentile: Top 90%
Synthesis and Biological Evaluation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Copper(II)/Rhodium(III)‐Catalyzed Three‐Component Sequential Annulation‐Olefination of 2‐Arylquinoxalines — Fucheng Yin, Yifan Chen, et al. · European Journal of Organic Chemistry (2024) | TGRS Research Map | TGRS